Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupivacaine wound infiltration for pain after laparoscopic cholecystectomy
NCT03958513Phase 2Completed
- Sponsor
- Bangabandhu Sheikh Mujib Medical University
- Start
- Jan 2019
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of bupivacaine in postoperative pain (2 arms), sponsored by Bangabandhu Sheikh Mujib Medical University. Primary endpoints: Post-operative pain: VAS at 12 hours and Post-operative pain: rating scale at 12 hours. Started Jan 2019; status: completed.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03958513.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03958513.